<DOC>
	<DOCNO>NCT00003909</DOCNO>
	<brief_summary>Radiation therapy use high-energy x-rays damage tumor cell . Drugs motexafin gadolinium may make tumor cell sensitive radiation therapy . Phase I trial study effectiveness motexafin gadolinium plus radiation therapy treat child newly diagnose brain stem glioma</brief_summary>
	<brief_title>Motexafin Gadolinium Plus Radiation Therapy Treating Children With Newly Diagnosed Brain Stem Glioma</brief_title>
	<detailed_description>OBJECTIVES : I . Determine maximum tolerate dose ( MTD ) schedule motexafin gadolinium administer prior radiotherapy child newly diagnose diffuse intrinsic pontine glioma . II . Determine toxic effect drug give MTD patient . III . Determine intratumor brain distribution drug magnetic resonance imaging ( MRI ) patient . OUTLINE : This dose-escalation study motexafin gadolinium . Approximately 2-5 hour radiotherapy , patient receive motexafin gadolinium IV 5 minute . Patients undergo radiotherapy 5 day week 6 week . Cohorts 3-6 patient receive escalate dos motexafin gadolinium MTD determine . The first cohort receives motexafin gadolinium 5 day week 3 week ; second cohort receives motexafin gadolinium 3 day week 6 week ; subsequent cohort receive motexafin gadolinium 5 day week 6 week . The MTD define dose precede 2 3 2 6 patient experience dose-limiting toxicity . Patients follow every 3 month 3 year . PROJECTED ACCRUAL : A maximum 24 patient accrue study within 2 year .</detailed_description>
	<mesh_term>Glioma</mesh_term>
	<mesh_term>Motexafin gadolinium</mesh_term>
	<criteria>Clinically radiographically ( MRI ) prove newly diagnose diffuse intrinsic brainstem glioma Greater 50 % intraaxial involvement pons , pons medulla , pons midbrain , entire brainstem Contiguous involvement thalamus upper cervical cord allow Performance status ECOG 02 More 2 month Absolute neutrophil count least 1,000/mm^3 Platelet count least 100,000/mm^3 Hemoglobin least 10.0 g/dL ( transfusion allow ) No glucose 6 phosphate dehydrogenase deficiency Bilirubin great 1.5 time normal SGOT SGPT less 1.5 time normal Creatinine great 1.5 time normal Creatinine clearance radioisotope glomerular filtration rate least 70 mL/min Not pregnant nursing Negative pregnancy test Fertile patient must use effective contraception No concurrent immunomodulating agent No concurrent chemotherapy Concurrent corticosteroid therapy allow increase intracranial pressure No prior cranial radiotherapy No prior motexafin gadolinium No concurrent experimental agent</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>21 Years</maximum_age>
	<verification_date>January 2013</verification_date>
</DOC>